Skip to content

Current ratio at other companies

Baxter International logo
Baxter InternationalBAX
1.9×-0.2×
Boston Scientific logo
Boston ScientificBSX
1.9×+0.4×
Merit Medical Systems logo
Merit Medical SystemsMMSI
5.1×+0.2×
Medtronic logo
MedtronicMDT
2.1×+0.3×
Abbott logo
AbbottABT
1.4×-0.4×
Cytokinetics logo
CytokineticsCYTK
4.2×-1.8×

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.44B+16.0%
Enterprise value$3.27B+21.8%
P/S4.4×-0.4×

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×

Where this comes from

Calculated from iRhythm Holdings, Inc. ’s reported figures.

Based on the most recent quarter.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's current ratio?
iRhythm Holdings, Inc. (IRTC) reported current ratio of 5.2× in Q1 2026.
How has iRhythm Holdings, Inc. 's current ratio changed year-over-year?
iRhythm Holdings, Inc. 's current ratio decreased by 9.6% year-over-year, from 5.7× to 5.2×.
What is the long-term trend for iRhythm Holdings, Inc. 's current ratio?
Over 5 years (2020 to 2025), iRhythm Holdings, Inc. 's current ratio has grown at a -4.3% compound annual growth rate (CAGR), from 5.8× to 4.6×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.